Deerfield Management Company, L.P. (Series C) Avid Bioservices, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$4.04 Billion
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.34 - $9.28 $474,212 - $694,116	74,797 Added 73.48%	176,586 $1.26 Million
Q1 2024 May 15, 2024	BUY	$5.86 - $8.79 $364,568 - $546,852	62,213 Added 157.2%	101,789 $681,000
Q4 2023 Feb 14, 2024	BUY	$4.64 - $9.56 $183,632 - $378,346	39,576 New	39,576 $257,000

Others Institutions Holding CDMO

# of Institutions

209

Shares Held

67.1M

Call Options Held

216K

Put Options Held

4.6K

Black Rock Inc. New York, NY

5.11M
Shares

$63.8 Million
0.0% of portfolio
Altra Vue Capital, LLC Bellevue, WA

3.8M
Shares

$47.4 Million
4.5% of portfolio
Vanguard Group Inc Valley Forge, PA

3.77M
Shares

$47.1 Million
0.0% of portfolio
Glazer Capital, LLC New York, NY

3.72M
Shares

$46.4 Million
3.11% of portfolio
Punch & Associates Investment Management, Inc. Edina, MN

2.88M
Shares

$36 Million
2.11% of portfolio

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account